Navigation Links
InterMune Sells Danoprevir Rights to Roche for $175 Million
Date:10/6/2010

BRISBANE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it has sold worldwide development and commercialization rights to danoprevir (also known as RG7227 or ITMN-191) to Hoffman-La Roche Inc. and F. Hoffman-La Roche Ltd. for $175 million in cash.  In connection with this transaction, the collaboration agreement that InterMune and Roche entered into in October 2006 has been terminated.  In addition, the companies are actively exploring ways to continue their ongoing work together on other HCV research programs.  InterMune noted that as a result of this transaction, the company will make no further investment in danoprevir and that, including net proceeds from the transaction, it currently expects to have a cash balance of approximately $290 million at the end of 2010.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "After conducting a careful review of our strategy and financial position, we have decided to divest our rights to danoprevir to Roche.  This transaction provides a very substantial non-dilutive cash infusion that allows us to continue to independently and aggressively pursue the registration and commercialization of pirfenidone in the US and EU, and eliminates our obligation to make significant ongoing investments related to the further development and commercialization of danoprevir.  We are now in a very strong financial position that provides us with the resources and flexibility to maximize the value of pirfenidone, our largest and nearest-term value creation opportunity."

Conference Call and Webcast Details

InterMune will host a conference call today at 4:30 p.m. EDT to discuss the transaction.  Interested investors and others may participate in the conference call by dialing 866-408-9480 (U.S.) or 706-643-9223 (international), con
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. InterMune to Present at 2010 Citi Health Care Conference
2. InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application
3. InterMune to Release First Quarter Financial Results on April 29
4. InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
5. InterMune Announces Proposed Public Offering of Common Stock
6. InterMune to Release Third Quarter Financial Results on November 5
7. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
8. InterMune to Present at Canaccord Adams Conference
9. InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
10. InterMune to Release Second Quarter Financial Results on August 6
11. InterMune to Present at Goldman Sachs Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Nov. 25, 2011  San Francisco-based healthcare IT company ... version of XMRI.com, a new B2C service that ... opinions online. The system utilizes ... leading national outsourced radiology service provider, USARAD.com. USARAD.com,s ...
... group at the University of Maryland (UMd), a multi-institution ... an age-old metallurgy technique to produce an alloy that ... sensors and micromechanical devices controlled by magnetism.* The alloy, ... other things, for not using rare-earth elements to achieve ...
... always shine and the breeze doesn,t always blow and therein ... power usable on a grand scale. If only there ... to store large quantities of excess power generated on windy ... as we,re fantasizing, let,s imagine the battery is cheap to ...
Cached Biology Technology:Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of 'XMRI.com,' New System by USARAD.com 2Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of 'XMRI.com,' New System by USARAD.com 3New magnetic-field-sensitive alloy could find use in novel micromechanical devices 2Nanoparticle electrode for batteries could make grid-scale power storage feasible 2Nanoparticle electrode for batteries could make grid-scale power storage feasible 3Nanoparticle electrode for batteries could make grid-scale power storage feasible 4
(Date:4/15/2014)... question of how social behavior has developed over the ... and Basel have gained new insights from the study ... food. Rather the siblings share what is available amongst ... Jol Meunier of the Evolutionary Biology section of the ... (JGU). The team of biologists from Mainz University and ...
(Date:4/15/2014)... Md. (April 15, 2014) The American Association ... award winners. All awards will be presented during ... Diego Marriott Hotel on Tuesday, April 29th at 7:30 ... (EB). , The 2014 award winners are: ... Jeffrey Laitman, PhD, of the Icahn School of Medicine ...
(Date:4/15/2014)... viral diseases in the world for which no pharmaceutical ... is spread by mosquitoes in the tropics, as well ... in Finland and is easily spread by the hands ... the elderly. , Researchers at Aalto University and the ... tests to prevent the spread of one type of ...
Breaking Biology News(10 mins):Sibling cooperation in earwig families gives clues to early evolution of social behavior 2American Association of Anatomists 2014 award winners 2Nanocrystalline cellulose modified into an efficient viral inhibitor 2
... by Johns Hopkins scientists has,found the first clear ... remarkable ability to recognize and respond to a ... of genes whose,only apparent function is to jump ... themselves out of the genetic material, and scientists,have ...
... patients suffering from liver,damage (cirrhosis) and failure may ... Southampton which may lead to new,life-saving treatments. There ... patient's only hope of survival is to receive ... Centre for Inflammation,Research, in collaboration with colleagues from ...
... a form of blue-green algae that lives independently ... to an article published in this week's online ... Sciences (PNAS).,"This new strain of Acaryochloris is unique ... says UO biology professor Michelle Wood. She obtained,samples ...
Cached Biology News:Jumping gene helps explain immune system's abilities 2Jumping gene helps explain immune system's abilities 3Research Gives Hope For Liver Damage 2Scientists discover unique microbe in California's largest lake 2Scientists discover unique microbe in California's largest lake 3Scientists discover unique microbe in California's largest lake 4Scientists discover unique microbe in California's largest lake 5
Quartz-Halogen, 100 W, High Intensity...
... 1;heading 2;Many mammalian ... experimental situations create ... transfection and other ... ViraPower Lentiviral Expression ...
The product contains 10 ml Dynabeads Epoxy (4.5 m). Supplied at 4 x 10 8 beads/ml...
...
Biology Products: